Payer PolicyActive
LAB.00040 Serum Biomarker Tests for Risk of Preeclampsia
ANTHEM-LAB.00040
Anthem
Effective: December 18, 2025
Updated: December 30, 2025
Policy Summary
This policy addresses serum biomarker tests used to diagnose, screen for, or assess risk of preeclampsia. Anthem considers these tests investigational and not medically necessary; they are not covered for any indication. There are no covered exceptions, and related codes (81599, 82105, 84163, 84704) are non-covered when used for preeclampsia risk assessment.
Coverage Criteria Preview
Key requirements from the full policy
"Serum biomarker tests to diagnose, screen for, or assess risk of preeclampsia are consideredinvestigational and not medically necessary."
Sign up to see full coverage criteria, indications, and limitations.